SCHEMBL20547362

SCHEMBL20547362

CCOC(=O)N1CCc2noc(-c3ccc(Cl)cc3)c2CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.53
CYP1A2 P05177 2/20 0.53
CYP2C19 P33261 2/20 0.53
HTT P42858 2/20 0.53
CYP2D6 P10635 1/20 0.53
CYP2C9 P11712 1/20 0.53
MAPT P10636 4/20 0.47
LMNA P02545 2/20 0.47
TSHR P16473 2/20 0.47
NPSR1 Q6W5P4 1/20 0.47
HRH2 P25021 1/20 0.46
HRH1 P35367 1/20 0.46
POLB P06746 1/20 0.46
ALDH1A1 P00352 4/20 0.45
KMT2A Q03164 3/20 0.45
MEN1 O00255 2/20 0.45
KDM4E B2RXH2 1/20 0.45
GAA P10253 1/20 0.44
MAPK1 P28482 1/20 0.44
HSD17B10 Q99714 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20546709 0.91 LMNA (0.51) SMN1; SMN2CYP1A2CYP2C19HTTCYP2D6
SCHEMBL20547217 0.89 LMNA (0.47) SMN1; SMN2CYP1A2CYP2C19HTTCYP2D6
SCHEMBL20547218 0.88 KMT2A (0.51) MAPTLMNATSHRALDH1A1KMT2A
SCHEMBL20547285 0.87 KCNH2 (0.56) SMN1; SMN2CYP1A2CYP2C19HTTCYP2D6
SCHEMBL20547246 0.82 NPC1 (0.53) SMN1; SMN2MAPTLMNATSHRHRH1
SCHEMBL20547359 0.82 DPP4 (0.48) SMN1; SMN2CYP1A2MAPTLMNATSHR
SCHEMBL20547288 0.81 LMNA (0.50) SMN1; SMN2HTTMAPTLMNATSHR
SCHEMBL20547293 0.80 NPC1 (0.54) SMN1; SMN2MAPTLMNATSHRHRH1
SCHEMBL20547245 0.78 NPC1 (0.53) SMN1; SMN2CYP1A2CYP2C19CYP2C9MAPT
SCHEMBL11832459 0.70 SMYD3 (0.53) SMN1; SMN2CYP1A2CYP2C19CYP2C9MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3560927-B1 AZEPINE DERIVATIVES ACTING AS 5-HT7 RECEPTOR MODULATORS KOREA INST SCI & TECH (KR) 2023-04-19 EP disclosed
EP-3560927-A1 AZEPINE DERIVATIVE ACTING AS 5-HT7 RECEPTOR MODULATOR Korea Institute of Science and Technology (KR) 2019-10-30 EP disclosed
US-10435408-B2 Azepine derivatives as 5-HT7 receptor modulators KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2019-10-08 US disclosed
US-20180312509-A1 AZEPINE DERIVATIVES AS 5-HT7 RECEPTOR MODULATORS KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2018-11-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180312509-A1 AZEPINE DERIVATIVES AS 5-HT7 RECEPTOR MODULATORS HTR7, HTR5A, HTR3A SMN1; SMN2 433/4885CYP1A2 586/4885CYP2C19 187/4885
US-10435408-B2 Azepine derivatives as 5-HT7 receptor modulators HTR7, HTR5A, HTR3A SMN1; SMN2 433/4885CYP1A2 586/4885CYP2C19 187/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.